Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)

NCT06159478 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER_GOV

Sponsor class

Conditions

Low-grade Glioma
Pancreatic Cancer

Interventions

DRUG: Binimetinib 15 MG

Sponsor

National Cancer Center, Japan

Collaborators

[object Object]